Regulatory Recon: Sage Shares Soar After Postpartum Depression Drug Meets Phase III Goals FDA Approves Merck Drug to Prevent Post-Stem Cell Transplant Infections (9 November 2017)
Recon
Regulatory NewsMichael Mezher
ReconRegulatory NewsMichael Mezher